Telehealth helps health system manage dramatic rise in patient referrals

 

During the COVID-19 pandemic, Geisinger saw referrals for behavioral health services grow at a much faster rate than usual. Restrictions on in-person care and clinician shortages made access to care difficult, leading to long wait times for appointments and potentially worse patient outcomes. To address the backlog issue, the 10-hospital integrated health network in northeast Pennsylvania partnered with a telehealth vendor to develop a standardized intake and triage workflow, combined with expanding its clinician workforce.

Ben Gonzales, operations manager II with Geisinger's department of psychiatry and behavioral health, explained the challenges the system faced dealing with the growing numbers of behavioral health patients and explained how telemedicine was leveraged to address patient needs. Gonzales spoke with Health Exec at the Healthcare Information Management Systems Society (HIMSS) 2023 meetin,g where he presented on his hospital experience adding virtual care services.

"Being a health system largely in central and northeastern Pennsylvania, we have a very rural service area, so we had to get pretty creative. In the second and third wave of COVID, we started to see the demand far overshadowed our capacity. We reached a point where we were getting about 180 referrals per day, and that is still the case to this day," Gonzales explained.

The health system did some internal recruitment to try and bolster its psychiatry and behavioral health program, but realized they needed a much faster way to expand care for their patients. They contracted with Iris Telehealth to bring on more than 20 telemedicine providers. 

Even though the pandemic is now in the past and telemedicine was used to address the needs during the COVID surge, Gonzales said telemedicine is here to stay in his health system.

"We are currently at 85% telemedicine encounters for outpatient encounters. For us, we see telemedicine growing. Now that we created that surge capacity, we are now looking at how can we enhance the telemedicine experience," he said. "For us, the amount of telemedicine will stay the same and it is now about honing that strategy and making it as effective as possible."  

When patients visit a brick and mortar clinic or hospital, they usually are given a clipboard to fill out a lot of information before their visit. They are now working on doing something similar electronically for telehealth visits to streamline the process and the data entry. 

"We already had a robust telemedicine offering and a full-fledged telemedicine team. Our patients and staff really do not know the difference between an Iris provider or a Geisinger provider. They are all using the same EMR, the same video platform interface to connect with patients," Gonzales said. 

The health system uses TeleDoc as its telemedicine platform, which allows scheduling within the Epic EMR that sends appointment invites to the patients. 

For health systems looking to build their telemedicine capacity, he said it is important to find a vendor that is seasoned so they can help work through and issues quickly because they have already dealt withy this things during previous telemedicine implementations. He said vendors that are willing to partner and co-develop the technology with you are also very helpful. 

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.